Archive for the ‘Colorectal Cancer’ category

Cancer Fundraiser

June 29th, 2010

The Farber Center for Radiation Oncology

Presents

ROCKS AGAINST CANCER

A Fundraising Event for Entertainment Industry Foundation
benefiting EIF Cancer Programs.

Thursday, Sept 16th 7pm to 11pm

BLACK TIE ROCK & ROLL STYLE!

To purchase tickets or donate click here: Rocks Against Cancer Tickets

The event will take place at the Angel Orensanz Foundation for the Arts, situated on 172 Norfolk Street in the former Ansche Chesed Synagogue, the venue boasts superbly maintained mid-19th century architecture.

The lounge-style space will feature cocktails and food as well as performances by The Rotten Hill Gang, a six-piece band from London fronted by Mick Jones of The Clash. Eclectic Method featuring London natives Jonny Wilson, Ian Edgar and Geoff Gamlen – who helped pioneer the emerging art of audio-visual mixing since first cutting U2’s Mysterious Ways music video with the Beastie Boys’ Intergalactic as an experiment back in 2002 will close out the night.

The event also includes a silent auction of jewelry by Stephen Webster—three-time winner of the “British Luxury Jeweller of the Year” award and 2008 winner of “UK Jewellery Brand of the Year”—including specially designed bracelets supporting the fight against cancer with net proceeds benefiting EIF’s Cancer programs. Webster is widely known as the jeweler to the stars; his celebrity client list includes Madonna, Elizabeth Taylor, Jennifer Lopez, Kim Cattrall, and Christina Aguilera among others.

Some of EIF’s cancer programs include: Stand Up To Cancer (SU2C)Woman’s Cancer Research Fund, Brains on Bikes, Right Action for Woman, and the National Colorectal Research Alliance

If you are arriving from out of town please contact the Smyth – part of the Thompson Hotels at 85 West Broadway phone: 212.587.7000. We have reserved rooms at a special rate under the group name Rocks Against Cancer.

A special thanks to our current sponsors at the time this blog went out: Stephen Webster, Matthew Robbins Desings, Svendka, Warren Tricomi, and Elekta Inc.

  • Share/Bookmark

Mayo researchers find that obesity-related biological factors can influence clinical outcome in colon cancer

March 15th, 2010

Researchers at the Mayo Clinic campus in Minnesota have found that obesity is associated with worse outcomes in patients who have already been diagnosed and treated for the cancer.

Their data also showed that depending on a patient’s gender, varying levels of obesity were associated with an increased risk of death ranging from 19 percent to 35 percent, compared to non-obese patients.

“We found that obesity is associated with more aggressive colon cancers, with the effect being stronger in men than in women,” says the study’s lead author, Frank Sinicrope, M.D., a Mayo Clinic medical oncologist. “Our data suggest that a little extra weight is okay, but body weight in the obesity range puts a patient at increased risk for cancer recurrence and spread and, based upon other studies, also would be expected to increase the risk of precancerous colon polyps and a second colon cancer.”

to read more on this study go here: Mayo Clinic News Feed

  • Share/Bookmark

Colon Cancer Month

February 28th, 2010

March is National Colorectal Cancer Awareness Month. Colorectal cancer is the second leading cause of cancer death in the United States.

Colorectal cancer usually develops slowly over a period of many years. Before a true cancer develops, it usually begins as a noncancerous polyp, which may eventually change into cancer. A polyp is a growth of tissue that develops on the lining of the colon or rectum. Certain kinds of polyps, called adenomatous polyps or adenomas, are most likely to become cancers, although most adenomas do not become cancerous. More than half of all individuals will eventually develop one or more adenomas. About 96% of colorectal cancers are adenocarcinomas, which evolve from glandular tissue. The great majority of colon and rectum cancers arise from an adenomatous polyp, which is visible through a scope or on an x-ray.

Colorectal cancer is equally common in men and women. An estimated 147,000 people will be diagnosed in 2010, and an estimated 50,000 people will die from the disease. With recommended screening, this cancer can be prevented (by removing polyps before they become cancerous) or detected early, when it can be more easily and successfully treated.

Help raise awareness at the colon cancer challenge

People who are at risk

Men and women age 50 and older
People who use tobacco, are obese or are sedentary
People with a personal or family history of colorectal cancer or benign (not cancerous) colorectal polyps
People with a personal or family history of inflammatory bowel disease, such as long standing ulcerative colitis or Crohn’s disease
People with a family history of inherited colorectal cancer

Early Detection
If you are at average risk for colorectal cancer, start having regular screening at age 50. If you are at greater risk, you may need to begin regular screening at an earlier age. The best time to get screened is before any symptoms appear.

Screening intervals for tests that find pre-cancer and cancer:
Colonoscopy: Every 10 years
Virtual colonoscopy: Every 5 years
Flexible sigmoidoscopy: Every 5 years
Double-contrast barium enema: Every 5 years

  • Share/Bookmark

Switch to our mobile site